[{"Assets_0_Q3_USD":582055000.0,"CommonStockSharesOutstanding_0_Q3_shares":156953000.0,"EarningsPerShareBasic_1_Q3_USD":0.39,"EarningsPerShareBasic_3_Q3_USD":-0.41,"EarningsPerShareDiluted_1_Q3_USD":0.37,"EarningsPerShareDiluted_3_Q3_USD":-0.41,"NetIncomeLoss_1_Q3_USD":60871000.0,"NetIncomeLoss_3_Q3_USD":-62866000.0,"StockholdersEquity_0_Q3_USD":84162000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":162641000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":155153000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":156411000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":155153000.0,"Ticker":"NKTR","CIK":"906709","name":"NEKTAR THERAPEUTICS","OfficialName":"Nektar Therapeutics  Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"862449342.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171108"}]